IARC cancer classification

   

The Wall Street Journal recently reported that a St. Louis jury ruled in Bayer’s favor this September, delivering the company its fifth consecutive trial victory.

Testing for chemical carcinogenicity using animals is timely, costly, and for some, morally wrong.